|

locally manufactured adoptive cellular therapy (ACT) product Clinical Trials

1 actively recruiting trial across 1 location

Also known as: ACT, Fast TIL

Pipeline

Phase 1: 1

Top Sponsors

  • David Bartlett, MD1

Indications

  • Metastasis to Pleura1
  • Pleural Effusion, Malignant1
  • Malignant Pleural Effusion1
  • Malignant Mesothelioma1
  • Lung Cancer1

Pittsburgh, Pennsylvania1 trial

Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease

AHN West Penn Hospital

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.